Resultados de la búsqueda 2111-2120 of 20221 for WHO
The purpose of this study is to determine the correlation between HER2 specific T-cell response in HER2-positive breast cancer patients with stage I-IV who ...
... who have received at least two prior lines of therapies. The study has 2 Modules: Module 1 for FL and Module 2 for DLBCL. EF-41/KEYNOTE D58: Phase 3 Study ...
... who did not have cancer. The increased risk of HF is observed as early as one year from diagnosis of cancer and overall, 7% of patients develop CHF (median ...
Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...
... Who is at risk? Aug. 22, 2024, 02:59 p.m. CDT · Mayo Clinic Minute: 4 ideas for avoiding the 'freshman 15' Aug. 21, 2024, 05:15 p.m. CDT · Mayo Clinic Minute ...
Implantable cardioverter defibrillator devices: When, how and who should discuss deactivation with patients: A systematic literature review. BMJ Supportive ...
Who should be screened for lung cancer? Centers for Disease Control and Prevention. https://www.cdc.gov/cancer/lung/basic_info/screening.htm. Accessed Oct ...
Medical guidelines: Who can join. National Marrow Donor Program. https://bethematch.org/support-the-cause/donate-bone-marrow/join-the-marrow-registry ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?